Lindbrook Capital, LLC Axogen, Inc. Transaction History
Lindbrook Capital, LLC
- $1.06 Billion
- Q1 2025
A detailed history of Lindbrook Capital, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 108 shares of AXGN stock, worth $1,195. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108
Previous 64
68.75%
Holding current value
$1,195
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AXGN
# of Institutions
191Shares Held
39.2MCall Options Held
61.7KPut Options Held
42.8K-
First Light Asset Management, LLC Edina, MN4.47MShares$49.5 Million10.62% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$36 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.6MShares$28.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$28.1 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.59MShares$17.6 Million0.54% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $468M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...